Sean McCutcheon
Stock Analyst at Raymond James
(2.75)
# 1,818
Out of 5,120 analysts
12
Total ratings
41.67%
Success rate
11.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Initiates: Outperform | $24 | $12.03 | +99.50% | 1 | Jan 9, 2026 | |
| RVMD Revolution Medicines | Maintains: Strong Buy | $72 → $76 | $97.16 | -21.78% | 2 | Oct 17, 2025 | |
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $7.71 | +55.64% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $13.99 | +364.62% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $6.52 | +38.04% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $2.54 | +333.07% | 1 | Jul 1, 2025 | |
| ENGN enGene Holdings | Initiates: Outperform | $23 | $10.00 | +130.00% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $12.11 | +230.31% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $65.16 | +7.43% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $17.15 | +401.46% | 1 | Mar 13, 2024 |
BridgeBio Oncology Therapeutics
Jan 9, 2026
Initiates: Outperform
Price Target: $24
Current: $12.03
Upside: +99.50%
Revolution Medicines
Oct 17, 2025
Maintains: Strong Buy
Price Target: $72 → $76
Current: $97.16
Upside: -21.78%
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $7.71
Upside: +55.64%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $13.99
Upside: +364.62%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $6.52
Upside: +38.04%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.54
Upside: +333.07%
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $10.00
Upside: +130.00%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $12.11
Upside: +230.31%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $65.16
Upside: +7.43%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $17.15
Upside: +401.46%